| Schedule of other financial income and expense |
| | | | | | | | | | | | | | | | | | | | | | Year ended December 31, | | | 2025 | | 2024 | | 2023 | | | | | (Euro, in thousands) | Fair value adjustments and net currency exchange differences: | | | | | | | | | | Net unrealized currency exchange gain/loss (-) | | € | (45,484) | | € | 22,727 | | € | (20,544) | Net realized currency exchange gain/loss (-) | | | 474 | | | (678) | | | (1,118) | Fair value re-measurement of warrants | | | — | | | 4 | | | 18 | Fair value gain/loss (-) on financial assets held at fair value | | | 1,175 | | | — | | | (390) | Gain from settlement of hedging instrument | | | 22,745 | | | — | | | — | Fair value gain/loss (-) on current financial investments | | | (18,266) | | | 73,742 | | | 38,286 | Total fair value adjustments and net currency exchange differences | | | (39,356) | | | 95,795 | | | 16,252 | | | | | | | | | | | Other financial income: | | | | | | | | | | Interest income | | | 46,339 | | | 89,378 | | | 79,290 | Discounting effect of non-current R&D incentives receivables | | | 1,648 | | | 1,132 | | | 617 | Discounting effect of other non-current liabilities | | | — | | | 395 | | | 318 | Other finance income | | | 64 | | | 223 | | | 24 | Total other financial income | | | 48,051 | | | 91,128 | | | 80,249 | | | | | | | | | | | Other financial expenses: | | | | | | | | | | Interest expenses | | | (1,034) | | | (911) | | | (1,770) | Discounting effect of other non-current liabilities | | | (1,183) | | | — | | | — | Other finance charges | | | (646) | | | (759) | | | (843) | Total other financial expense | | | (2,863) | | | (1,670) | | | (2,613) | | | | | | | | | | | Total net financial result | | € | 5,832 | | € | 185,253 | | € | 93,888 |
|